Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group.

Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20.

PMID:
28007457
2.

An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed.

Sherman S, Amzal B, Calvo E, Wang X, Park J, Liu Z, Lin C, Casciano R.

Clin Ther. 2015 Oct 22. pii: S0149-2918(15)01144-3. doi: 10.1016/j.clinthera.2015.09.013. [Epub ahead of print]

3.

Real-World Hepatitis C Treatment Strategies in Denmark.

Jalbert J, Pisini M, van Sanden S, Nalpas C, Bakshi S, Duchesne I, Amzal B.

Value Health. 2015 Nov;18(7):A592-3. doi: 10.1016/j.jval.2015.09.1529. Epub 2015 Oct 20. No abstract available.

4.

Age Related Consultation Rates of Clinically-Diagnosed Influenza And Acute Respiratory Illnesses Observed Through A Network of Gp Practices Across England.

Wiecek W, Amzal B, Bakshi S, Patel V, Van Staa T.

Value Health. 2015 Nov;18(7):A579. doi: 10.1016/j.jval.2015.09.1931. Epub 2015 Oct 20. No abstract available.

5.

Can Grapefruit Juice Make Safe Drugs Unsafe or Ineffective? An Evidence-Based Answer.

Quignot N, Amzal B.

Value Health. 2015 Nov;18(7):A542. doi: 10.1016/j.jval.2015.09.1715. Epub 2015 Oct 20. No abstract available.

6.

Impact of Drug's Presentation on Patients' Perception of Treatment's Risks & Benefits Through New Ordinal Gee Modelling Method: Results from Imi Protect Wp6.

Wiecek W, Karcher H, Amzal B, Beyer A, Hoekstra T, Fasolo B, Hillege JL.

Value Health. 2015 Nov;18(7):A484-5. doi: 10.1016/j.jval.2015.09.1326. Epub 2015 Oct 20. No abstract available.

7.

The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom: Results From The Pgrx-3 Real World Dataset.

Nordon C, Abenhaim L, Worsfold A, Amzal B, Rossignol M, Grimaldi-Bensouda L.

Value Health. 2015 Nov;18(7):A399. doi: 10.1016/j.jval.2015.09.913. Epub 2015 Oct 20. No abstract available.

8.

Literature review of visual representation of the results of benefit-risk assessments of medicinal products.

Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D; PROTECT Benefit-Risk group.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):238-50. doi: 10.1002/pds.3880. Epub 2015 Nov 2. Review.

PMID:
26521865
9.

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.

Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S.

PLoS One. 2015 Aug 28;10(8):e0137368. doi: 10.1371/journal.pone.0137368. eCollection 2015. No abstract available.

10.

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.

Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S.

PLoS One. 2015 Jun 26;10(6):e0130917. doi: 10.1371/journal.pone.0130917. eCollection 2015. No abstract available.

11.

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.

Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S.

PLoS One. 2015 May 19;10(5):e0126647. doi: 10.1371/journal.pone.0126647. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137368. PLoS One. 2015;10(6):e0130917.

12.

Predictive Modelling for Optimal Target Population and Real-World Study Design: An Example In Mother-To-Child Transmission of HIV.

Amzal B.

Value Health. 2014 Nov;17(7):A546-7. doi: 10.1016/j.jval.2014.08.1773. Epub 2014 Oct 26. No abstract available.

13.

Applicability and feasibility of systematic review for performing evidence-based risk assessment in food and feed safety.

Aiassa E, Higgins JP, Frampton GK, Greiner M, Afonso A, Amzal B, Deeks J, Dorne JL, Glanville J, Lövei GL, Nienstedt K, O'connor AM, Pullin AS, Rajić A, Verloo D.

Crit Rev Food Sci Nutr. 2015;55(7):1026-34. doi: 10.1080/10408398.2013.769933. Review.

PMID:
25191830
14.

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.

Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13. Review.

PMID:
24821575
15.

Use of historical control data for assessing treatment effects in clinical trials.

Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L.

Pharm Stat. 2014 Jan-Feb;13(1):41-54. doi: 10.1002/pst.1589. Epub 2013 Aug 5. Review.

16.

Population effects and variability.

Dorne JL, Amzal B, Bois F, Crépet A, Tressou J, Verger P.

Methods Mol Biol. 2012;929:521-81. Review.

PMID:
23007442
17.

Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand.

Duong T, Jourdain G, Ngo-Giang-Huong N, Le Cœur S, Kantipong P, Buranabanjasatean S, Leenasirimakul P, Ariyadej S, Tansuphasawasdikul S, Thongpaen S, Lallemant M; Program for HIV Prevention and Treatment Study Group.

PLoS One. 2012;7(8):e43375. Epub 2012 Aug 15.

18.

Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand.

Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M; Program for HIV Prevention and Treatment Study Group.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):91-8. doi: 10.1097/QAI.0b013e31824bd33f.

PMID:
22293548
19.

Relation between dietary cadmium intake and biomarkers of cadmium exposure in premenopausal women accounting for body iron stores.

Julin B, Vahter M, Amzal B, Wolk A, Berglund M, Åkesson A.

Environ Health. 2011 Dec 16;10:105. doi: 10.1186/1476-069X-10-105.

20.

Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.

Ngo-Giang-Huong N, Jourdain G, Amzal B, Sang-a-gad P, Lertkoonalak R, Eiamsirikit N, Tansuphasawasdikul S, Buranawanitchakorn Y, Yutthakasemsunt N, Mekviwattanawong S, McIntosh K, Lallemant M; Program for HIV Prevention and Treatment (PHPT) study group.

PLoS One. 2011;6(11):e27427. doi: 10.1371/journal.pone.0027427. Epub 2011 Nov 23.

Supplemental Content

Loading ...
Support Center